nodes	percent_of_prediction	percent_of_DWPC	metapath
Rivaroxaban—ABCB1—epilepsy syndrome	0.161	1	CbGaD
Rivaroxaban—CYP3A5—Oxcarbazepine—epilepsy syndrome	0.0468	0.0841	CbGbCtD
Rivaroxaban—ABCB1—Levetiracetam—epilepsy syndrome	0.0333	0.0599	CbGbCtD
Rivaroxaban—CYP3A5—Carbamazepine—epilepsy syndrome	0.0294	0.0528	CbGbCtD
Rivaroxaban—CYP3A5—Phenytoin—epilepsy syndrome	0.0264	0.0474	CbGbCtD
Rivaroxaban—CYP3A5—Phenobarbital—epilepsy syndrome	0.0235	0.0422	CbGbCtD
Rivaroxaban—CYP3A5—Midazolam—epilepsy syndrome	0.0232	0.0416	CbGbCtD
Rivaroxaban—ABCB1—Clobazam—epilepsy syndrome	0.0231	0.0415	CbGbCtD
Rivaroxaban—CYP3A5—Diazepam—epilepsy syndrome	0.0223	0.04	CbGbCtD
Rivaroxaban—ABCB1—Lamotrigine—epilepsy syndrome	0.0222	0.0399	CbGbCtD
Rivaroxaban—ABCB1—Carbamazepine—epilepsy syndrome	0.0191	0.0344	CbGbCtD
Rivaroxaban—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.0183	0.0328	CbGbCtD
Rivaroxaban—CYP3A5—Valproic Acid—epilepsy syndrome	0.0176	0.0316	CbGbCtD
Rivaroxaban—ABCB1—Phenytoin—epilepsy syndrome	0.0172	0.0308	CbGbCtD
Rivaroxaban—CYP3A4—Trimethadione—epilepsy syndrome	0.017	0.0305	CbGbCtD
Rivaroxaban—CYP3A4—Felbamate—epilepsy syndrome	0.017	0.0305	CbGbCtD
Rivaroxaban—CYP3A4—Fosphenytoin—epilepsy syndrome	0.016	0.0287	CbGbCtD
Rivaroxaban—ABCB1—Phenobarbital—epilepsy syndrome	0.0153	0.0275	CbGbCtD
Rivaroxaban—ABCB1—Midazolam—epilepsy syndrome	0.0151	0.0271	CbGbCtD
Rivaroxaban—ABCB1—Diazepam—epilepsy syndrome	0.0145	0.0261	CbGbCtD
Rivaroxaban—CYP3A4—Clonazepam—epilepsy syndrome	0.0144	0.0259	CbGbCtD
Rivaroxaban—CYP3A4—Clobazam—epilepsy syndrome	0.0138	0.0249	CbGbCtD
Rivaroxaban—CYP3A4—Rufinamide—epilepsy syndrome	0.0118	0.0211	CbGbCtD
Rivaroxaban—CYP3A4—Carbamazepine—epilepsy syndrome	0.0115	0.0206	CbGbCtD
Rivaroxaban—CYP3A4—Primidone—epilepsy syndrome	0.0107	0.0192	CbGbCtD
Rivaroxaban—CYP3A4—Phenytoin—epilepsy syndrome	0.0103	0.0185	CbGbCtD
Rivaroxaban—CYP3A4—Propofol—epilepsy syndrome	0.00959	0.0172	CbGbCtD
Rivaroxaban—CYP3A4—Phenobarbital—epilepsy syndrome	0.00917	0.0165	CbGbCtD
Rivaroxaban—CYP3A4—Acetazolamide—epilepsy syndrome	0.00917	0.0165	CbGbCtD
Rivaroxaban—CYP3A4—Midazolam—epilepsy syndrome	0.00904	0.0162	CbGbCtD
Rivaroxaban—CYP3A4—Diazepam—epilepsy syndrome	0.00869	0.0156	CbGbCtD
Rivaroxaban—CYP3A4—Zonisamide—epilepsy syndrome	0.00848	0.0152	CbGbCtD
Rivaroxaban—CYP3A4—Valproic Acid—epilepsy syndrome	0.00685	0.0123	CbGbCtD
Rivaroxaban—CYP3A4—Topiramate—epilepsy syndrome	0.00618	0.0111	CbGbCtD
Rivaroxaban—CYP2J2—forebrain—epilepsy syndrome	0.00027	0.115	CbGeAlD
Rivaroxaban—CYP2J2—telencephalon—epilepsy syndrome	0.000248	0.106	CbGeAlD
Rivaroxaban—CYP2J2—medulla oblongata—epilepsy syndrome	0.000195	0.083	CbGeAlD
Rivaroxaban—F10—head—epilepsy syndrome	0.000189	0.0802	CbGeAlD
Rivaroxaban—CYP2J2—midbrain—epilepsy syndrome	0.000178	0.0758	CbGeAlD
Rivaroxaban—CYP2J2—spinal cord—epilepsy syndrome	0.000174	0.074	CbGeAlD
Rivaroxaban—CYP2J2—head—epilepsy syndrome	0.000155	0.0658	CbGeAlD
Rivaroxaban—CYP2J2—nervous system—epilepsy syndrome	0.000147	0.0623	CbGeAlD
Rivaroxaban—CYP2J2—central nervous system—epilepsy syndrome	0.000141	0.06	CbGeAlD
Rivaroxaban—CYP2J2—cerebellum—epilepsy syndrome	0.000138	0.0587	CbGeAlD
Rivaroxaban—CYP2J2—brain—epilepsy syndrome	0.000112	0.0476	CbGeAlD
Rivaroxaban—Diarrhoea—Diazepam—epilepsy syndrome	0.0001	0.000452	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Lamotrigine—epilepsy syndrome	0.0001	0.000452	CcSEcCtD
Rivaroxaban—Ill-defined disorder—Pregabalin—epilepsy syndrome	0.0001	0.000451	CcSEcCtD
Rivaroxaban—Sinusitis—Topiramate—epilepsy syndrome	9.99e-05	0.00045	CcSEcCtD
Rivaroxaban—Rash—Levetiracetam—epilepsy syndrome	9.97e-05	0.000449	CcSEcCtD
Rivaroxaban—Anaemia—Pregabalin—epilepsy syndrome	9.97e-05	0.000449	CcSEcCtD
Rivaroxaban—Dermatitis—Levetiracetam—epilepsy syndrome	9.96e-05	0.000449	CcSEcCtD
Rivaroxaban—Asthenia—Zonisamide—epilepsy syndrome	9.95e-05	0.000449	CcSEcCtD
Rivaroxaban—Agranulocytosis—Topiramate—epilepsy syndrome	9.94e-05	0.000448	CcSEcCtD
Rivaroxaban—Dry mouth—Valproic Acid—epilepsy syndrome	9.93e-05	0.000448	CcSEcCtD
Rivaroxaban—Headache—Levetiracetam—epilepsy syndrome	9.9e-05	0.000447	CcSEcCtD
Rivaroxaban—Angioedema—Pregabalin—epilepsy syndrome	9.85e-05	0.000444	CcSEcCtD
Rivaroxaban—Hypersensitivity—Clonazepam—epilepsy syndrome	9.85e-05	0.000444	CcSEcCtD
Rivaroxaban—Dizziness—Vigabatrin—epilepsy syndrome	9.84e-05	0.000443	CcSEcCtD
Rivaroxaban—Pruritus—Zonisamide—epilepsy syndrome	9.81e-05	0.000442	CcSEcCtD
Rivaroxaban—Hypersensitivity—Phenytoin—epilepsy syndrome	9.78e-05	0.000441	CcSEcCtD
Rivaroxaban—Oedema—Valproic Acid—epilepsy syndrome	9.74e-05	0.000439	CcSEcCtD
Rivaroxaban—Anaphylactic shock—Valproic Acid—epilepsy syndrome	9.74e-05	0.000439	CcSEcCtD
Rivaroxaban—Urticaria—Lamotrigine—epilepsy syndrome	9.73e-05	0.000439	CcSEcCtD
Rivaroxaban—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	9.73e-05	0.000439	CcSEcCtD
Rivaroxaban—Malaise—Pregabalin—epilepsy syndrome	9.73e-05	0.000438	CcSEcCtD
Rivaroxaban—Nausea—Propofol—epilepsy syndrome	9.72e-05	0.000438	CcSEcCtD
Rivaroxaban—Vomiting—Fosphenytoin—epilepsy syndrome	9.7e-05	0.000437	CcSEcCtD
Rivaroxaban—Diarrhoea—Felbamate—epilepsy syndrome	9.7e-05	0.000437	CcSEcCtD
Rivaroxaban—Abdominal pain—Lamotrigine—epilepsy syndrome	9.69e-05	0.000437	CcSEcCtD
Rivaroxaban—Dizziness—Diazepam—epilepsy syndrome	9.68e-05	0.000437	CcSEcCtD
Rivaroxaban—Infection—Valproic Acid—epilepsy syndrome	9.67e-05	0.000436	CcSEcCtD
Rivaroxaban—Syncope—Pregabalin—epilepsy syndrome	9.67e-05	0.000436	CcSEcCtD
Rivaroxaban—Rash—Fosphenytoin—epilepsy syndrome	9.62e-05	0.000434	CcSEcCtD
Rivaroxaban—Dermatitis—Fosphenytoin—epilepsy syndrome	9.61e-05	0.000433	CcSEcCtD
Rivaroxaban—Haemoglobin—Topiramate—epilepsy syndrome	9.61e-05	0.000433	CcSEcCtD
Rivaroxaban—Asthenia—Clonazepam—epilepsy syndrome	9.59e-05	0.000432	CcSEcCtD
Rivaroxaban—Back pain—Gabapentin—epilepsy syndrome	9.57e-05	0.000431	CcSEcCtD
Rivaroxaban—Headache—Fosphenytoin—epilepsy syndrome	9.56e-05	0.000431	CcSEcCtD
Rivaroxaban—Hepatitis—Topiramate—epilepsy syndrome	9.56e-05	0.000431	CcSEcCtD
Rivaroxaban—Haemorrhage—Topiramate—epilepsy syndrome	9.56e-05	0.000431	CcSEcCtD
Rivaroxaban—Nervous system disorder—Valproic Acid—epilepsy syndrome	9.55e-05	0.00043	CcSEcCtD
Rivaroxaban—Asthenia—Phenytoin—epilepsy syndrome	9.53e-05	0.00043	CcSEcCtD
Rivaroxaban—Nausea—Midazolam—epilepsy syndrome	9.51e-05	0.000429	CcSEcCtD
Rivaroxaban—Muscle spasms—Gabapentin—epilepsy syndrome	9.51e-05	0.000429	CcSEcCtD
Rivaroxaban—Tachycardia—Valproic Acid—epilepsy syndrome	9.5e-05	0.000428	CcSEcCtD
Rivaroxaban—Diarrhoea—Zonisamide—epilepsy syndrome	9.49e-05	0.000428	CcSEcCtD
Rivaroxaban—Loss of consciousness—Pregabalin—epilepsy syndrome	9.48e-05	0.000427	CcSEcCtD
Rivaroxaban—Asthenia—Oxcarbazepine—epilepsy syndrome	9.48e-05	0.000427	CcSEcCtD
Rivaroxaban—Pruritus—Clonazepam—epilepsy syndrome	9.46e-05	0.000426	CcSEcCtD
Rivaroxaban—Vomiting—Vigabatrin—epilepsy syndrome	9.46e-05	0.000426	CcSEcCtD
Rivaroxaban—Skin disorder—Valproic Acid—epilepsy syndrome	9.46e-05	0.000426	CcSEcCtD
Rivaroxaban—Urinary tract disorder—Topiramate—epilepsy syndrome	9.44e-05	0.000426	CcSEcCtD
Rivaroxaban—Pruritus—Phenytoin—epilepsy syndrome	9.4e-05	0.000424	CcSEcCtD
Rivaroxaban—Connective tissue disorder—Topiramate—epilepsy syndrome	9.39e-05	0.000423	CcSEcCtD
Rivaroxaban—Nausea—Levetiracetam—epilepsy syndrome	9.39e-05	0.000423	CcSEcCtD
Rivaroxaban—Rash—Vigabatrin—epilepsy syndrome	9.38e-05	0.000423	CcSEcCtD
Rivaroxaban—Dizziness—Felbamate—epilepsy syndrome	9.37e-05	0.000423	CcSEcCtD
Rivaroxaban—Dermatitis—Vigabatrin—epilepsy syndrome	9.37e-05	0.000422	CcSEcCtD
Rivaroxaban—Urethral disorder—Topiramate—epilepsy syndrome	9.37e-05	0.000422	CcSEcCtD
Rivaroxaban—Pruritus—Oxcarbazepine—epilepsy syndrome	9.35e-05	0.000421	CcSEcCtD
Rivaroxaban—Hypersensitivity—Carbamazepine—epilepsy syndrome	9.34e-05	0.000421	CcSEcCtD
Rivaroxaban—Headache—Vigabatrin—epilepsy syndrome	9.32e-05	0.00042	CcSEcCtD
Rivaroxaban—Vomiting—Diazepam—epilepsy syndrome	9.31e-05	0.00042	CcSEcCtD
Rivaroxaban—Rash—Diazepam—epilepsy syndrome	9.23e-05	0.000416	CcSEcCtD
Rivaroxaban—Dermatitis—Diazepam—epilepsy syndrome	9.22e-05	0.000416	CcSEcCtD
Rivaroxaban—Chest pain—Pregabalin—epilepsy syndrome	9.18e-05	0.000414	CcSEcCtD
Rivaroxaban—Ill-defined disorder—Gabapentin—epilepsy syndrome	9.18e-05	0.000414	CcSEcCtD
Rivaroxaban—Dizziness—Zonisamide—epilepsy syndrome	9.17e-05	0.000414	CcSEcCtD
Rivaroxaban—Headache—Diazepam—epilepsy syndrome	9.17e-05	0.000414	CcSEcCtD
Rivaroxaban—Diarrhoea—Clonazepam—epilepsy syndrome	9.15e-05	0.000412	CcSEcCtD
Rivaroxaban—Anaemia—Gabapentin—epilepsy syndrome	9.14e-05	0.000412	CcSEcCtD
Rivaroxaban—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	9.12e-05	0.000411	CcSEcCtD
Rivaroxaban—Hypotension—Valproic Acid—epilepsy syndrome	9.1e-05	0.00041	CcSEcCtD
Rivaroxaban—Asthenia—Carbamazepine—epilepsy syndrome	9.1e-05	0.00041	CcSEcCtD
Rivaroxaban—Diarrhoea—Phenytoin—epilepsy syndrome	9.09e-05	0.00041	CcSEcCtD
Rivaroxaban—Discomfort—Pregabalin—epilepsy syndrome	9.07e-05	0.000409	CcSEcCtD
Rivaroxaban—Nausea—Fosphenytoin—epilepsy syndrome	9.06e-05	0.000409	CcSEcCtD
Rivaroxaban—Diarrhoea—Oxcarbazepine—epilepsy syndrome	9.04e-05	0.000407	CcSEcCtD
Rivaroxaban—Erythema multiforme—Topiramate—epilepsy syndrome	9.04e-05	0.000407	CcSEcCtD
Rivaroxaban—Angioedema—Gabapentin—epilepsy syndrome	9.04e-05	0.000407	CcSEcCtD
Rivaroxaban—Hypersensitivity—Lamotrigine—epilepsy syndrome	9.03e-05	0.000407	CcSEcCtD
Rivaroxaban—Vomiting—Felbamate—epilepsy syndrome	9.01e-05	0.000406	CcSEcCtD
Rivaroxaban—Dry mouth—Pregabalin—epilepsy syndrome	8.98e-05	0.000405	CcSEcCtD
Rivaroxaban—Pruritus—Carbamazepine—epilepsy syndrome	8.97e-05	0.000404	CcSEcCtD
Rivaroxaban—Rash—Felbamate—epilepsy syndrome	8.94e-05	0.000403	CcSEcCtD
Rivaroxaban—Eye disorder—Topiramate—epilepsy syndrome	8.93e-05	0.000403	CcSEcCtD
Rivaroxaban—Dermatitis—Felbamate—epilepsy syndrome	8.93e-05	0.000402	CcSEcCtD
Rivaroxaban—Malaise—Gabapentin—epilepsy syndrome	8.92e-05	0.000402	CcSEcCtD
Rivaroxaban—Headache—Felbamate—epilepsy syndrome	8.88e-05	0.0004	CcSEcCtD
Rivaroxaban—Cardiac disorder—Topiramate—epilepsy syndrome	8.87e-05	0.0004	CcSEcCtD
Rivaroxaban—Syncope—Gabapentin—epilepsy syndrome	8.87e-05	0.0004	CcSEcCtD
Rivaroxaban—Dizziness—Clonazepam—epilepsy syndrome	8.84e-05	0.000399	CcSEcCtD
Rivaroxaban—Nausea—Vigabatrin—epilepsy syndrome	8.83e-05	0.000398	CcSEcCtD
Rivaroxaban—Vomiting—Zonisamide—epilepsy syndrome	8.82e-05	0.000398	CcSEcCtD
Rivaroxaban—Oedema—Pregabalin—epilepsy syndrome	8.8e-05	0.000397	CcSEcCtD
Rivaroxaban—Anaphylactic shock—Pregabalin—epilepsy syndrome	8.8e-05	0.000397	CcSEcCtD
Rivaroxaban—Asthenia—Lamotrigine—epilepsy syndrome	8.79e-05	0.000396	CcSEcCtD
Rivaroxaban—Dizziness—Phenytoin—epilepsy syndrome	8.78e-05	0.000396	CcSEcCtD
Rivaroxaban—Rash—Zonisamide—epilepsy syndrome	8.75e-05	0.000394	CcSEcCtD
Rivaroxaban—Infection—Pregabalin—epilepsy syndrome	8.74e-05	0.000394	CcSEcCtD
Rivaroxaban—Dermatitis—Zonisamide—epilepsy syndrome	8.74e-05	0.000394	CcSEcCtD
Rivaroxaban—Dizziness—Oxcarbazepine—epilepsy syndrome	8.74e-05	0.000394	CcSEcCtD
Rivaroxaban—Nausea—Diazepam—epilepsy syndrome	8.7e-05	0.000392	CcSEcCtD
Rivaroxaban—Loss of consciousness—Gabapentin—epilepsy syndrome	8.69e-05	0.000392	CcSEcCtD
Rivaroxaban—Headache—Zonisamide—epilepsy syndrome	8.69e-05	0.000392	CcSEcCtD
Rivaroxaban—Dyspnoea—Valproic Acid—epilepsy syndrome	8.68e-05	0.000391	CcSEcCtD
Rivaroxaban—Diarrhoea—Carbamazepine—epilepsy syndrome	8.67e-05	0.000391	CcSEcCtD
Rivaroxaban—Angiopathy—Topiramate—epilepsy syndrome	8.67e-05	0.000391	CcSEcCtD
Rivaroxaban—Pruritus—Lamotrigine—epilepsy syndrome	8.67e-05	0.000391	CcSEcCtD
Rivaroxaban—Shock—Pregabalin—epilepsy syndrome	8.66e-05	0.00039	CcSEcCtD
Rivaroxaban—Immune system disorder—Topiramate—epilepsy syndrome	8.63e-05	0.000389	CcSEcCtD
Rivaroxaban—Nervous system disorder—Pregabalin—epilepsy syndrome	8.63e-05	0.000389	CcSEcCtD
Rivaroxaban—Mediastinal disorder—Topiramate—epilepsy syndrome	8.61e-05	0.000388	CcSEcCtD
Rivaroxaban—Tachycardia—Pregabalin—epilepsy syndrome	8.59e-05	0.000387	CcSEcCtD
Rivaroxaban—Dyspepsia—Valproic Acid—epilepsy syndrome	8.57e-05	0.000386	CcSEcCtD
Rivaroxaban—Skin disorder—Pregabalin—epilepsy syndrome	8.55e-05	0.000385	CcSEcCtD
Rivaroxaban—Vomiting—Clonazepam—epilepsy syndrome	8.5e-05	0.000383	CcSEcCtD
Rivaroxaban—Vomiting—Phenytoin—epilepsy syndrome	8.44e-05	0.000381	CcSEcCtD
Rivaroxaban—Rash—Clonazepam—epilepsy syndrome	8.43e-05	0.00038	CcSEcCtD
Rivaroxaban—Dermatitis—Clonazepam—epilepsy syndrome	8.42e-05	0.00038	CcSEcCtD
Rivaroxaban—Chest pain—Gabapentin—epilepsy syndrome	8.42e-05	0.00038	CcSEcCtD
Rivaroxaban—Nausea—Felbamate—epilepsy syndrome	8.42e-05	0.00038	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	8.4e-05	0.000379	CcSEcCtD
Rivaroxaban—Vomiting—Oxcarbazepine—epilepsy syndrome	8.4e-05	0.000379	CcSEcCtD
Rivaroxaban—Fatigue—Valproic Acid—epilepsy syndrome	8.39e-05	0.000378	CcSEcCtD
Rivaroxaban—Dizziness—Carbamazepine—epilepsy syndrome	8.38e-05	0.000378	CcSEcCtD
Rivaroxaban—Diarrhoea—Lamotrigine—epilepsy syndrome	8.38e-05	0.000378	CcSEcCtD
Rivaroxaban—Headache—Clonazepam—epilepsy syndrome	8.38e-05	0.000378	CcSEcCtD
Rivaroxaban—Rash—Phenytoin—epilepsy syndrome	8.37e-05	0.000377	CcSEcCtD
Rivaroxaban—Dermatitis—Phenytoin—epilepsy syndrome	8.37e-05	0.000377	CcSEcCtD
Rivaroxaban—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	8.36e-05	0.000377	CcSEcCtD
Rivaroxaban—Rash—Oxcarbazepine—epilepsy syndrome	8.33e-05	0.000376	CcSEcCtD
Rivaroxaban—Constipation—Valproic Acid—epilepsy syndrome	8.33e-05	0.000375	CcSEcCtD
Rivaroxaban—Pain—Valproic Acid—epilepsy syndrome	8.33e-05	0.000375	CcSEcCtD
Rivaroxaban—Dermatitis—Oxcarbazepine—epilepsy syndrome	8.32e-05	0.000375	CcSEcCtD
Rivaroxaban—Headache—Phenytoin—epilepsy syndrome	8.32e-05	0.000375	CcSEcCtD
Rivaroxaban—Discomfort—Gabapentin—epilepsy syndrome	8.32e-05	0.000375	CcSEcCtD
Rivaroxaban—Headache—Oxcarbazepine—epilepsy syndrome	8.28e-05	0.000373	CcSEcCtD
Rivaroxaban—Nausea—Zonisamide—epilepsy syndrome	8.24e-05	0.000371	CcSEcCtD
Rivaroxaban—Dry mouth—Gabapentin—epilepsy syndrome	8.23e-05	0.000371	CcSEcCtD
Rivaroxaban—Hypotension—Pregabalin—epilepsy syndrome	8.22e-05	0.000371	CcSEcCtD
Rivaroxaban—Dizziness—Lamotrigine—epilepsy syndrome	8.1e-05	0.000365	CcSEcCtD
Rivaroxaban—Anaphylactic shock—Gabapentin—epilepsy syndrome	8.07e-05	0.000364	CcSEcCtD
Rivaroxaban—Oedema—Gabapentin—epilepsy syndrome	8.07e-05	0.000364	CcSEcCtD
Rivaroxaban—Vomiting—Carbamazepine—epilepsy syndrome	8.06e-05	0.000363	CcSEcCtD
Rivaroxaban—Back pain—Topiramate—epilepsy syndrome	8.05e-05	0.000363	CcSEcCtD
Rivaroxaban—Feeling abnormal—Valproic Acid—epilepsy syndrome	8.02e-05	0.000362	CcSEcCtD
Rivaroxaban—Infection—Gabapentin—epilepsy syndrome	8.02e-05	0.000361	CcSEcCtD
Rivaroxaban—Muscle spasms—Topiramate—epilepsy syndrome	8e-05	0.000361	CcSEcCtD
Rivaroxaban—Rash—Carbamazepine—epilepsy syndrome	7.99e-05	0.00036	CcSEcCtD
Rivaroxaban—Dermatitis—Carbamazepine—epilepsy syndrome	7.99e-05	0.00036	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	7.96e-05	0.000359	CcSEcCtD
Rivaroxaban—Nausea—Clonazepam—epilepsy syndrome	7.94e-05	0.000358	CcSEcCtD
Rivaroxaban—Headache—Carbamazepine—epilepsy syndrome	7.94e-05	0.000358	CcSEcCtD
Rivaroxaban—Shock—Gabapentin—epilepsy syndrome	7.94e-05	0.000358	CcSEcCtD
Rivaroxaban—Nervous system disorder—Gabapentin—epilepsy syndrome	7.91e-05	0.000357	CcSEcCtD
Rivaroxaban—Nausea—Phenytoin—epilepsy syndrome	7.89e-05	0.000356	CcSEcCtD
Rivaroxaban—Tachycardia—Gabapentin—epilepsy syndrome	7.88e-05	0.000355	CcSEcCtD
Rivaroxaban—Dyspnoea—Pregabalin—epilepsy syndrome	7.85e-05	0.000354	CcSEcCtD
Rivaroxaban—Nausea—Oxcarbazepine—epilepsy syndrome	7.85e-05	0.000354	CcSEcCtD
Rivaroxaban—Skin disorder—Gabapentin—epilepsy syndrome	7.84e-05	0.000353	CcSEcCtD
Rivaroxaban—Vomiting—Lamotrigine—epilepsy syndrome	7.79e-05	0.000351	CcSEcCtD
Rivaroxaban—Urticaria—Valproic Acid—epilepsy syndrome	7.73e-05	0.000349	CcSEcCtD
Rivaroxaban—Rash—Lamotrigine—epilepsy syndrome	7.72e-05	0.000348	CcSEcCtD
Rivaroxaban—Ill-defined disorder—Topiramate—epilepsy syndrome	7.72e-05	0.000348	CcSEcCtD
Rivaroxaban—Dermatitis—Lamotrigine—epilepsy syndrome	7.72e-05	0.000348	CcSEcCtD
Rivaroxaban—Abdominal pain—Valproic Acid—epilepsy syndrome	7.7e-05	0.000347	CcSEcCtD
Rivaroxaban—Anaemia—Topiramate—epilepsy syndrome	7.69e-05	0.000347	CcSEcCtD
Rivaroxaban—Headache—Lamotrigine—epilepsy syndrome	7.68e-05	0.000346	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	7.6e-05	0.000343	CcSEcCtD
Rivaroxaban—Fatigue—Pregabalin—epilepsy syndrome	7.59e-05	0.000342	CcSEcCtD
Rivaroxaban—Hypotension—Gabapentin—epilepsy syndrome	7.54e-05	0.00034	CcSEcCtD
Rivaroxaban—Nausea—Carbamazepine—epilepsy syndrome	7.53e-05	0.000339	CcSEcCtD
Rivaroxaban—Constipation—Pregabalin—epilepsy syndrome	7.53e-05	0.000339	CcSEcCtD
Rivaroxaban—Pain—Pregabalin—epilepsy syndrome	7.53e-05	0.000339	CcSEcCtD
Rivaroxaban—Malaise—Topiramate—epilepsy syndrome	7.5e-05	0.000338	CcSEcCtD
Rivaroxaban—Syncope—Topiramate—epilepsy syndrome	7.46e-05	0.000336	CcSEcCtD
Rivaroxaban—Loss of consciousness—Topiramate—epilepsy syndrome	7.31e-05	0.00033	CcSEcCtD
Rivaroxaban—Nausea—Lamotrigine—epilepsy syndrome	7.28e-05	0.000328	CcSEcCtD
Rivaroxaban—Feeling abnormal—Pregabalin—epilepsy syndrome	7.25e-05	0.000327	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Pregabalin—epilepsy syndrome	7.2e-05	0.000324	CcSEcCtD
Rivaroxaban—Dyspnoea—Gabapentin—epilepsy syndrome	7.2e-05	0.000324	CcSEcCtD
Rivaroxaban—Hypersensitivity—Valproic Acid—epilepsy syndrome	7.17e-05	0.000323	CcSEcCtD
Rivaroxaban—Dyspepsia—Gabapentin—epilepsy syndrome	7.1e-05	0.00032	CcSEcCtD
Rivaroxaban—Chest pain—Topiramate—epilepsy syndrome	7.08e-05	0.000319	CcSEcCtD
Rivaroxaban—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	7.03e-05	0.000317	CcSEcCtD
Rivaroxaban—Discomfort—Topiramate—epilepsy syndrome	7e-05	0.000315	CcSEcCtD
Rivaroxaban—Urticaria—Pregabalin—epilepsy syndrome	6.99e-05	0.000315	CcSEcCtD
Rivaroxaban—Asthenia—Valproic Acid—epilepsy syndrome	6.98e-05	0.000315	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	6.97e-05	0.000314	CcSEcCtD
Rivaroxaban—Fatigue—Gabapentin—epilepsy syndrome	6.96e-05	0.000314	CcSEcCtD
Rivaroxaban—Abdominal pain—Pregabalin—epilepsy syndrome	6.96e-05	0.000314	CcSEcCtD
Rivaroxaban—Dry mouth—Topiramate—epilepsy syndrome	6.93e-05	0.000312	CcSEcCtD
Rivaroxaban—Pain—Gabapentin—epilepsy syndrome	6.9e-05	0.000311	CcSEcCtD
Rivaroxaban—Constipation—Gabapentin—epilepsy syndrome	6.9e-05	0.000311	CcSEcCtD
Rivaroxaban—Pruritus—Valproic Acid—epilepsy syndrome	6.89e-05	0.000311	CcSEcCtD
Rivaroxaban—Oedema—Topiramate—epilepsy syndrome	6.79e-05	0.000306	CcSEcCtD
Rivaroxaban—Infection—Topiramate—epilepsy syndrome	6.75e-05	0.000304	CcSEcCtD
Rivaroxaban—Shock—Topiramate—epilepsy syndrome	6.68e-05	0.000301	CcSEcCtD
Rivaroxaban—Diarrhoea—Valproic Acid—epilepsy syndrome	6.66e-05	0.0003	CcSEcCtD
Rivaroxaban—Nervous system disorder—Topiramate—epilepsy syndrome	6.66e-05	0.0003	CcSEcCtD
Rivaroxaban—Feeling abnormal—Gabapentin—epilepsy syndrome	6.65e-05	0.0003	CcSEcCtD
Rivaroxaban—Tachycardia—Topiramate—epilepsy syndrome	6.63e-05	0.000299	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Gabapentin—epilepsy syndrome	6.6e-05	0.000298	CcSEcCtD
Rivaroxaban—Skin disorder—Topiramate—epilepsy syndrome	6.6e-05	0.000297	CcSEcCtD
Rivaroxaban—Hypersensitivity—Pregabalin—epilepsy syndrome	6.48e-05	0.000292	CcSEcCtD
Rivaroxaban—Dizziness—Valproic Acid—epilepsy syndrome	6.44e-05	0.00029	CcSEcCtD
Rivaroxaban—Urticaria—Gabapentin—epilepsy syndrome	6.41e-05	0.000289	CcSEcCtD
Rivaroxaban—Abdominal pain—Gabapentin—epilepsy syndrome	6.38e-05	0.000288	CcSEcCtD
Rivaroxaban—Hypotension—Topiramate—epilepsy syndrome	6.34e-05	0.000286	CcSEcCtD
Rivaroxaban—Asthenia—Pregabalin—epilepsy syndrome	6.31e-05	0.000285	CcSEcCtD
Rivaroxaban—Pruritus—Pregabalin—epilepsy syndrome	6.23e-05	0.000281	CcSEcCtD
Rivaroxaban—Vomiting—Valproic Acid—epilepsy syndrome	6.19e-05	0.000279	CcSEcCtD
Rivaroxaban—Rash—Valproic Acid—epilepsy syndrome	6.14e-05	0.000277	CcSEcCtD
Rivaroxaban—Dermatitis—Valproic Acid—epilepsy syndrome	6.13e-05	0.000276	CcSEcCtD
Rivaroxaban—Headache—Valproic Acid—epilepsy syndrome	6.1e-05	0.000275	CcSEcCtD
Rivaroxaban—Dyspnoea—Topiramate—epilepsy syndrome	6.05e-05	0.000273	CcSEcCtD
Rivaroxaban—Diarrhoea—Pregabalin—epilepsy syndrome	6.02e-05	0.000271	CcSEcCtD
Rivaroxaban—Dyspepsia—Topiramate—epilepsy syndrome	5.98e-05	0.000269	CcSEcCtD
Rivaroxaban—Hypersensitivity—Gabapentin—epilepsy syndrome	5.95e-05	0.000268	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Topiramate—epilepsy syndrome	5.86e-05	0.000264	CcSEcCtD
Rivaroxaban—Fatigue—Topiramate—epilepsy syndrome	5.85e-05	0.000264	CcSEcCtD
Rivaroxaban—Dizziness—Pregabalin—epilepsy syndrome	5.82e-05	0.000262	CcSEcCtD
Rivaroxaban—Pain—Topiramate—epilepsy syndrome	5.81e-05	0.000262	CcSEcCtD
Rivaroxaban—Constipation—Topiramate—epilepsy syndrome	5.81e-05	0.000262	CcSEcCtD
Rivaroxaban—Asthenia—Gabapentin—epilepsy syndrome	5.79e-05	0.000261	CcSEcCtD
Rivaroxaban—Nausea—Valproic Acid—epilepsy syndrome	5.78e-05	0.000261	CcSEcCtD
Rivaroxaban—Pruritus—Gabapentin—epilepsy syndrome	5.71e-05	0.000257	CcSEcCtD
Rivaroxaban—Vomiting—Pregabalin—epilepsy syndrome	5.6e-05	0.000252	CcSEcCtD
Rivaroxaban—Feeling abnormal—Topiramate—epilepsy syndrome	5.6e-05	0.000252	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Topiramate—epilepsy syndrome	5.55e-05	0.00025	CcSEcCtD
Rivaroxaban—Rash—Pregabalin—epilepsy syndrome	5.55e-05	0.00025	CcSEcCtD
Rivaroxaban—Dermatitis—Pregabalin—epilepsy syndrome	5.54e-05	0.00025	CcSEcCtD
Rivaroxaban—Diarrhoea—Gabapentin—epilepsy syndrome	5.52e-05	0.000249	CcSEcCtD
Rivaroxaban—Headache—Pregabalin—epilepsy syndrome	5.51e-05	0.000249	CcSEcCtD
Rivaroxaban—Urticaria—Topiramate—epilepsy syndrome	5.39e-05	0.000243	CcSEcCtD
Rivaroxaban—Abdominal pain—Topiramate—epilepsy syndrome	5.37e-05	0.000242	CcSEcCtD
Rivaroxaban—Dizziness—Gabapentin—epilepsy syndrome	5.34e-05	0.000241	CcSEcCtD
Rivaroxaban—Nausea—Pregabalin—epilepsy syndrome	5.23e-05	0.000236	CcSEcCtD
Rivaroxaban—Vomiting—Gabapentin—epilepsy syndrome	5.13e-05	0.000231	CcSEcCtD
Rivaroxaban—Rash—Gabapentin—epilepsy syndrome	5.09e-05	0.000229	CcSEcCtD
Rivaroxaban—Dermatitis—Gabapentin—epilepsy syndrome	5.08e-05	0.000229	CcSEcCtD
Rivaroxaban—Headache—Gabapentin—epilepsy syndrome	5.06e-05	0.000228	CcSEcCtD
Rivaroxaban—ABCB1—forebrain—epilepsy syndrome	5.05e-05	0.0215	CbGeAlD
Rivaroxaban—Hypersensitivity—Topiramate—epilepsy syndrome	5e-05	0.000226	CcSEcCtD
Rivaroxaban—Asthenia—Topiramate—epilepsy syndrome	4.87e-05	0.00022	CcSEcCtD
Rivaroxaban—Pruritus—Topiramate—epilepsy syndrome	4.8e-05	0.000217	CcSEcCtD
Rivaroxaban—Nausea—Gabapentin—epilepsy syndrome	4.79e-05	0.000216	CcSEcCtD
Rivaroxaban—Diarrhoea—Topiramate—epilepsy syndrome	4.65e-05	0.000209	CcSEcCtD
Rivaroxaban—ABCB1—telencephalon—epilepsy syndrome	4.64e-05	0.0197	CbGeAlD
Rivaroxaban—Dizziness—Topiramate—epilepsy syndrome	4.49e-05	0.000202	CcSEcCtD
Rivaroxaban—Vomiting—Topiramate—epilepsy syndrome	4.32e-05	0.000195	CcSEcCtD
Rivaroxaban—Rash—Topiramate—epilepsy syndrome	4.28e-05	0.000193	CcSEcCtD
Rivaroxaban—Dermatitis—Topiramate—epilepsy syndrome	4.28e-05	0.000193	CcSEcCtD
Rivaroxaban—Headache—Topiramate—epilepsy syndrome	4.25e-05	0.000192	CcSEcCtD
Rivaroxaban—Nausea—Topiramate—epilepsy syndrome	4.03e-05	0.000182	CcSEcCtD
Rivaroxaban—CYP3A4—nervous system—epilepsy syndrome	3.87e-05	0.0165	CbGeAlD
Rivaroxaban—CYP3A4—central nervous system—epilepsy syndrome	3.73e-05	0.0159	CbGeAlD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—JUNB—epilepsy syndrome	3.7e-05	0.000636	CbGpPWpGaD
Rivaroxaban—ABCB1—medulla oblongata—epilepsy syndrome	3.65e-05	0.0155	CbGeAlD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	3.54e-05	0.000607	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—CYP2D6—epilepsy syndrome	3.53e-05	0.000605	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PDXK—epilepsy syndrome	3.44e-05	0.00059	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—CERS1—epilepsy syndrome	3.44e-05	0.00059	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—L2HGDH—epilepsy syndrome	3.44e-05	0.00059	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—GLUD1—epilepsy syndrome	3.44e-05	0.00059	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—FAR1—epilepsy syndrome	3.44e-05	0.00059	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—ADK—epilepsy syndrome	3.44e-05	0.00059	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—CA13—epilepsy syndrome	3.42e-05	0.000587	CbGpPWpGaD
Rivaroxaban—F10—Metabolism of proteins—POMC—epilepsy syndrome	3.41e-05	0.000584	CbGpPWpGaD
Rivaroxaban—ABCB1—HIF-1-alpha transcription factor network—JUN—epilepsy syndrome	3.4e-05	0.000584	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—ADRA2A—epilepsy syndrome	3.36e-05	0.000576	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—BCHE—epilepsy syndrome	3.35e-05	0.000574	CbGpPWpGaD
Rivaroxaban—F10—Metabolism of proteins—CCL2—epilepsy syndrome	3.33e-05	0.000572	CbGpPWpGaD
Rivaroxaban—ABCB1—midbrain—epilepsy syndrome	3.33e-05	0.0142	CbGeAlD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—APOD—epilepsy syndrome	3.26e-05	0.00056	CbGpPWpGaD
Rivaroxaban—ABCB1—spinal cord—epilepsy syndrome	3.25e-05	0.0138	CbGeAlD
Rivaroxaban—CYP2J2—Metabolism—SLC2A1—epilepsy syndrome	3.19e-05	0.000547	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—SLC1A1—epilepsy syndrome	3.18e-05	0.000546	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—SLC12A2—epilepsy syndrome	3.18e-05	0.000546	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—PLCB1—epilepsy syndrome	3.16e-05	0.000541	CbGpPWpGaD
Rivaroxaban—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—epilepsy syndrome	3.15e-05	0.00054	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—TH—epilepsy syndrome	3.15e-05	0.00054	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PNPO—epilepsy syndrome	3.14e-05	0.000539	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—NHLRC1—epilepsy syndrome	3.14e-05	0.000539	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—EPM2A—epilepsy syndrome	3.14e-05	0.000539	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—GAMT—epilepsy syndrome	3.14e-05	0.000539	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	3.1e-05	0.000531	CbGpPWpGaD
Rivaroxaban—CYP3A4—Biological oxidations—CYP2C19—epilepsy syndrome	3.08e-05	0.000529	CbGpPWpGaD
Rivaroxaban—CYP3A4—Biological oxidations—CYP11A1—epilepsy syndrome	3.06e-05	0.000526	CbGpPWpGaD
Rivaroxaban—ABCB1—Allograft Rejection—IL1B—epilepsy syndrome	3.04e-05	0.000522	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metapathway biotransformation—CYP2C19—epilepsy syndrome	3.04e-05	0.000522	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—GABRA5—epilepsy syndrome	3.03e-05	0.000521	CbGpPWpGaD
Rivaroxaban—ABCB1—Allograft Rejection—CASP3—epilepsy syndrome	3.03e-05	0.00052	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metapathway biotransformation—CYP11A1—epilepsy syndrome	3.02e-05	0.000518	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—epilepsy syndrome	3e-05	0.000514	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—epilepsy syndrome	2.98e-05	0.000512	CbGpPWpGaD
Rivaroxaban—ABCB1—HIF-1-alpha transcription factor network—VEGFA—epilepsy syndrome	2.97e-05	0.00051	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—QDPR—epilepsy syndrome	2.92e-05	0.000501	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—CA4—epilepsy syndrome	2.92e-05	0.000501	CbGpPWpGaD
Rivaroxaban—CYP3A5—Biological oxidations—POMC—epilepsy syndrome	2.91e-05	0.0005	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—ARHGEF9—epilepsy syndrome	2.91e-05	0.000499	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—SLC17A7—epilepsy syndrome	2.91e-05	0.000499	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—GABRA1—epilepsy syndrome	2.91e-05	0.000499	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—GABRB3—epilepsy syndrome	2.91e-05	0.000499	CbGpPWpGaD
Rivaroxaban—ABCB1—head—epilepsy syndrome	2.89e-05	0.0123	CbGeAlD
Rivaroxaban—F10—Hemostasis—SRC—epilepsy syndrome	2.79e-05	0.000479	CbGpPWpGaD
Rivaroxaban—CYP3A4—Biological oxidations—CYP2D6—epilepsy syndrome	2.76e-05	0.000474	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—COX3—epilepsy syndrome	2.75e-05	0.000471	CbGpPWpGaD
Rivaroxaban—ABCB1—nervous system—epilepsy syndrome	2.74e-05	0.0117	CbGeAlD
Rivaroxaban—CYP3A4—Metapathway biotransformation—CYP2D6—epilepsy syndrome	2.73e-05	0.000468	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—VEGFA—epilepsy syndrome	2.72e-05	0.000467	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—SLC1A2—epilepsy syndrome	2.7e-05	0.000464	CbGpPWpGaD
Rivaroxaban—ABCB1—central nervous system—epilepsy syndrome	2.64e-05	0.0112	CbGeAlD
Rivaroxaban—CYP2J2—Metabolism—HMOX1—epilepsy syndrome	2.63e-05	0.00045	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—CACNA2D2—epilepsy syndrome	2.61e-05	0.000447	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—KCNB1—epilepsy syndrome	2.61e-05	0.000447	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PFKL—epilepsy syndrome	2.61e-05	0.000447	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—SLCO1A2—epilepsy syndrome	2.61e-05	0.000447	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—SLC6A8—epilepsy syndrome	2.61e-05	0.000447	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—CERS1—epilepsy syndrome	2.59e-05	0.000445	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PDXK—epilepsy syndrome	2.59e-05	0.000445	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—L2HGDH—epilepsy syndrome	2.59e-05	0.000445	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—FAR1—epilepsy syndrome	2.59e-05	0.000445	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—ADK—epilepsy syndrome	2.59e-05	0.000445	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—GLUD1—epilepsy syndrome	2.59e-05	0.000445	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—CAT—epilepsy syndrome	2.59e-05	0.000444	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—GABRB2—epilepsy syndrome	2.58e-05	0.000443	CbGpPWpGaD
Rivaroxaban—ABCB1—cerebellum—epilepsy syndrome	2.58e-05	0.011	CbGeAlD
Rivaroxaban—ABCB1—Allograft Rejection—VEGFA—epilepsy syndrome	2.57e-05	0.000442	CbGpPWpGaD
Rivaroxaban—CYP3A4—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	2.55e-05	0.000437	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—AQP1—epilepsy syndrome	2.54e-05	0.000436	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—ABCB1—epilepsy syndrome	2.52e-05	0.000432	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—TRPV1—epilepsy syndrome	2.47e-05	0.000424	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—NEU1—epilepsy syndrome	2.38e-05	0.000409	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—UPB1—epilepsy syndrome	2.38e-05	0.000409	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—ATIC—epilepsy syndrome	2.38e-05	0.000409	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—SLC8A1—epilepsy syndrome	2.38e-05	0.000408	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PNPO—epilepsy syndrome	2.37e-05	0.000407	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—GAMT—epilepsy syndrome	2.37e-05	0.000407	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—EPM2A—epilepsy syndrome	2.37e-05	0.000407	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—NHLRC1—epilepsy syndrome	2.37e-05	0.000407	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—GPX1—epilepsy syndrome	2.34e-05	0.000402	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—AQP4—epilepsy syndrome	2.3e-05	0.000394	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—SLC1A3—epilepsy syndrome	2.3e-05	0.000394	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—HSD17B4—epilepsy syndrome	2.29e-05	0.000393	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—epilepsy syndrome	2.27e-05	0.000389	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PPP1R3C—epilepsy syndrome	2.22e-05	0.00038	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—GBE1—epilepsy syndrome	2.22e-05	0.00038	CbGpPWpGaD
Rivaroxaban—ABCB1—Allograft Rejection—TNF—epilepsy syndrome	2.21e-05	0.000378	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—CA4—epilepsy syndrome	2.21e-05	0.000378	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—QDPR—epilepsy syndrome	2.21e-05	0.000378	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	2.2e-05	0.000378	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CA13—epilepsy syndrome	2.11e-05	0.000362	CbGpPWpGaD
Rivaroxaban—ABCB1—brain—epilepsy syndrome	2.09e-05	0.00891	CbGeAlD
Rivaroxaban—CYP3A5—Metabolism—ASAH1—epilepsy syndrome	2.08e-05	0.000357	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—COX3—epilepsy syndrome	2.07e-05	0.000356	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—AGT—epilepsy syndrome	2.05e-05	0.000352	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	2.05e-05	0.000352	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—STXBP1—epilepsy syndrome	2.03e-05	0.000348	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—APOE—epilepsy syndrome	2.01e-05	0.000345	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—epilepsy syndrome	1.98e-05	0.000339	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—NT5E—epilepsy syndrome	1.97e-05	0.000339	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—ALAD—epilepsy syndrome	1.97e-05	0.000339	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—SLCO1A2—epilepsy syndrome	1.97e-05	0.000337	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PFKL—epilepsy syndrome	1.97e-05	0.000337	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—CACNA2D2—epilepsy syndrome	1.97e-05	0.000337	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—KCNB1—epilepsy syndrome	1.97e-05	0.000337	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—SLC6A8—epilepsy syndrome	1.97e-05	0.000337	CbGpPWpGaD
Rivaroxaban—ABCB1—HIF-1-alpha transcription factor network—AKT1—epilepsy syndrome	1.9e-05	0.000325	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—ALDH7A1—epilepsy syndrome	1.88e-05	0.000323	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—CACNA1A—epilepsy syndrome	1.88e-05	0.000323	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	1.87e-05	0.000322	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—ST3GAL3—epilepsy syndrome	1.84e-05	0.000316	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	1.83e-05	0.000313	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—ADSL—epilepsy syndrome	1.81e-05	0.00031	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—UPB1—epilepsy syndrome	1.8e-05	0.000308	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—NEU1—epilepsy syndrome	1.8e-05	0.000308	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—ATIC—epilepsy syndrome	1.8e-05	0.000308	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—epilepsy syndrome	1.79e-05	0.000307	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—GLUL—epilepsy syndrome	1.77e-05	0.000304	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—CACNA1D—epilepsy syndrome	1.74e-05	0.000298	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—AKT1—epilepsy syndrome	1.74e-05	0.000298	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—HSD17B4—epilepsy syndrome	1.73e-05	0.000297	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—POMC—epilepsy syndrome	1.73e-05	0.000297	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—epilepsy syndrome	1.7e-05	0.000291	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—GBE1—epilepsy syndrome	1.67e-05	0.000287	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PPP1R3C—epilepsy syndrome	1.67e-05	0.000287	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—TXNRD1—epilepsy syndrome	1.63e-05	0.000279	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—epilepsy syndrome	1.61e-05	0.000277	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CERS1—epilepsy syndrome	1.6e-05	0.000274	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—FAR1—epilepsy syndrome	1.6e-05	0.000274	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PDXK—epilepsy syndrome	1.6e-05	0.000274	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—L2HGDH—epilepsy syndrome	1.6e-05	0.000274	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ADK—epilepsy syndrome	1.6e-05	0.000274	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—GLUD1—epilepsy syndrome	1.6e-05	0.000274	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—AQP1—epilepsy syndrome	1.58e-05	0.000271	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—ALB—epilepsy syndrome	1.58e-05	0.00027	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—ASAH1—epilepsy syndrome	1.57e-05	0.00027	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	1.55e-05	0.000266	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—STXBP1—epilepsy syndrome	1.53e-05	0.000262	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—epilepsy syndrome	1.5e-05	0.000257	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—NT5E—epilepsy syndrome	1.49e-05	0.000256	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—ALAD—epilepsy syndrome	1.49e-05	0.000256	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	1.48e-05	0.000254	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—GAMT—epilepsy syndrome	1.46e-05	0.000251	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—NHLRC1—epilepsy syndrome	1.46e-05	0.000251	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—EPM2A—epilepsy syndrome	1.46e-05	0.000251	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PNPO—epilepsy syndrome	1.46e-05	0.000251	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—epilepsy syndrome	1.45e-05	0.000249	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—KCNJ11—epilepsy syndrome	1.43e-05	0.000245	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—CHRM3—epilepsy syndrome	1.43e-05	0.000245	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—ALDH7A1—epilepsy syndrome	1.42e-05	0.000244	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—CACNA1A—epilepsy syndrome	1.42e-05	0.000244	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—ST3GAL3—epilepsy syndrome	1.39e-05	0.000239	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—PTGS2—epilepsy syndrome	1.38e-05	0.000237	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—ADSL—epilepsy syndrome	1.36e-05	0.000234	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CA4—epilepsy syndrome	1.36e-05	0.000233	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—QDPR—epilepsy syndrome	1.36e-05	0.000233	CbGpPWpGaD
Rivaroxaban—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	1.35e-05	0.000232	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—GLUL—epilepsy syndrome	1.34e-05	0.000229	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—CACNA1D—epilepsy syndrome	1.31e-05	0.000225	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—epilepsy syndrome	1.3e-05	0.000224	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—COX3—epilepsy syndrome	1.28e-05	0.000219	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—epilepsy syndrome	1.27e-05	0.000218	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—TXNRD1—epilepsy syndrome	1.23e-05	0.00021	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	1.22e-05	0.000209	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PFKL—epilepsy syndrome	1.21e-05	0.000208	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	1.21e-05	0.000208	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	1.21e-05	0.000208	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	1.21e-05	0.000208	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	1.21e-05	0.000208	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—AVP—epilepsy syndrome	1.21e-05	0.000207	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—AQP1—epilepsy syndrome	1.19e-05	0.000204	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—ABCG2—epilepsy syndrome	1.16e-05	0.0002	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—CYP2C19—epilepsy syndrome	1.13e-05	0.000195	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—CYP11A1—epilepsy syndrome	1.13e-05	0.000193	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—NEU1—epilepsy syndrome	1.11e-05	0.00019	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ATIC—epilepsy syndrome	1.11e-05	0.00019	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—UPB1—epilepsy syndrome	1.11e-05	0.00019	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	1.09e-05	0.000187	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—KCNJ11—epilepsy syndrome	1.08e-05	0.000185	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—CHRM3—epilepsy syndrome	1.08e-05	0.000185	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	1.07e-05	0.000183	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—GBE1—epilepsy syndrome	1.03e-05	0.000177	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	1.03e-05	0.000177	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—CYP2D6—epilepsy syndrome	1.02e-05	0.000174	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	9.68e-06	0.000166	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—ADRA2A—epilepsy syndrome	9.68e-06	0.000166	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—BCHE—epilepsy syndrome	9.64e-06	0.000165	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	9.42e-06	0.000162	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—SLC2A1—epilepsy syndrome	9.2e-06	0.000158	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—NT5E—epilepsy syndrome	9.18e-06	0.000157	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ALAD—epilepsy syndrome	9.18e-06	0.000157	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PLCB1—epilepsy syndrome	9.1e-06	0.000156	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—TH—epilepsy syndrome	9.07e-06	0.000155	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—ABCG2—epilepsy syndrome	8.78e-06	0.000151	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	8.76e-06	0.00015	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	8.76e-06	0.00015	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	8.57e-06	0.000147	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—CYP2C19—epilepsy syndrome	8.56e-06	0.000147	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—CYP11A1—epilepsy syndrome	8.5e-06	0.000146	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ADSL—epilepsy syndrome	8.39e-06	0.000144	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—GLUL—epilepsy syndrome	8.23e-06	0.000141	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	8.11e-06	0.000139	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	8.08e-06	0.000139	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—CYP2D6—epilepsy syndrome	7.67e-06	0.000132	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—HMOX1—epilepsy syndrome	7.57e-06	0.00013	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	7.56e-06	0.00013	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—CAT—epilepsy syndrome	7.47e-06	0.000128	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—AQP1—epilepsy syndrome	7.34e-06	0.000126	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	7.32e-06	0.000126	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—ADRA2A—epilepsy syndrome	7.31e-06	0.000125	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—BCHE—epilepsy syndrome	7.28e-06	0.000125	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—ABCB1—epilepsy syndrome	7.26e-06	0.000125	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—SLC2A1—epilepsy syndrome	6.94e-06	0.000119	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—AKT1—epilepsy syndrome	6.93e-06	0.000119	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PLCB1—epilepsy syndrome	6.87e-06	0.000118	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—TH—epilepsy syndrome	6.84e-06	0.000117	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—GPX1—epilepsy syndrome	6.75e-06	0.000116	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	6.64e-06	0.000114	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	6.64e-06	0.000114	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—AGT—epilepsy syndrome	5.92e-06	0.000102	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—APOE—epilepsy syndrome	5.8e-06	9.95e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—HMOX1—epilepsy syndrome	5.71e-06	9.79e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—CAT—epilepsy syndrome	5.63e-06	9.66e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	5.41e-06	9.28e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	5.27e-06	9.04e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	5.24e-06	8.99e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—GPX1—epilepsy syndrome	5.09e-06	8.74e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—POMC—epilepsy syndrome	4.98e-06	8.55e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	4.73e-06	8.11e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—ALB—epilepsy syndrome	4.54e-06	7.79e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	4.5e-06	7.72e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—BCHE—epilepsy syndrome	4.48e-06	7.69e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—AGT—epilepsy syndrome	4.47e-06	7.66e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—APOE—epilepsy syndrome	4.38e-06	7.51e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	4.28e-06	7.34e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	4.23e-06	7.26e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—TH—epilepsy syndrome	4.21e-06	7.23e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PTGS2—epilepsy syndrome	3.97e-06	6.82e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—POMC—epilepsy syndrome	3.76e-06	6.45e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	3.52e-06	6.03e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CAT—epilepsy syndrome	3.47e-06	5.95e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—ALB—epilepsy syndrome	3.43e-06	5.88e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	3.38e-06	5.79e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—GPX1—epilepsy syndrome	3.14e-06	5.38e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PTGS2—epilepsy syndrome	3e-06	5.14e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—AGT—epilepsy syndrome	2.75e-06	4.72e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—APOE—epilepsy syndrome	2.7e-06	4.63e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—POMC—epilepsy syndrome	2.32e-06	3.97e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ALB—epilepsy syndrome	2.11e-06	3.62e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—AKT1—epilepsy syndrome	2e-06	3.43e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	1.85e-06	3.17e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—AKT1—epilepsy syndrome	1.51e-06	2.59e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—AKT1—epilepsy syndrome	9.29e-07	1.59e-05	CbGpPWpGaD
